MedPath

Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy

Phase 3
Completed
Conditions
Colorectal Carcinoma
Interventions
Registration Number
NCT01324284
Lead Sponsor
Asian Institute of Gastroenterology, India
Brief Summary

Lubiprostone as an adjunct to the standard bowel preparation regime the quality of bowel preparation can be improved for a good colonoscopic examination without missing lesions and complications.

Detailed Description

Objectives:

1. Primary:

* Same day Low volume PEG with placebo (Arm 1) versus same day low volume PEG with Lubiprostone (Arm 2)

* Waiting time for colonoscopic procedure and quality of bowel preparation

2. Secondary:

* Quality of bowel preparation without Dietary restriction (Modified bowel preparation regime without Fiber diet restrictions)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
442
Inclusion Criteria
  1. All adult patient referred for colonoscopy to AIG
  2. Age 18 - 75 years old
Exclusion Criteria
  1. Acute GI bleeding.
  2. Patient of bowel preparation regime other than excepted for the study.
  3. Renal insufficiency.
  4. Dementia.
  5. Symptomatic heart failure.
  6. Recent Myocardial Infarction.
  7. Patients with ileus.
  8. Suspected bowel obstruction.
  9. Prior alimentary tract surgery.
  10. Significant gastroparesis.
  11. Gastric outlet obstruction.
  12. Toxic colitis or megacolon.
  13. Pregnant or lactating patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LubiprostoneLubiprostoneLubiprostone with PEG solution versus Placebo with PEG solution
Primary Outcome Measures
NameTimeMethod
Quality of bowel preparation in Same day Low volume PEG with placebo versus same day low volume PEG with Lubiprostone2 months

Quality of bowel preparation is based on Boston Bowel Preparation Score (BBPS)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath